Holen Sie sich die Stockscreener-App
46.50
0.28%
0.15
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Royalty Pharma and J&J partner to develop autoimmune treatment - Yahoo Finance
Royalty Pharma commits $500M to J&J autoimmune drug development By Investing.com - Investing.com India
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases - Bitget
Johnson & Johnson taps Royalty Pharma for $500M autoimmune drug push - Stock Titan
SG Americas Securities LLC Buys 234,629 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Cooper Investors PTY Ltd. - MarketBeat
Eastern Bank Acquires 263,867 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Wedge Capital Management L L P NC Lowers Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Wealth Enhancement Advisory Services LLC Buys 165,451 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma Refreshes Leadership As AI And Asia Shape Valuation Story - Yahoo Finance
Royalty Pharma PLC (NASDAQ:RPRX) Given Average Rating of "Buy" by Analysts - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Emerges as a Compelling Value Investment - ChartMill
Royalty Pharma (RPRX) Valuation Check As New AI And Deal-Making Leaders Take Charge - Sahm
Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT - MSN
Royalty Pharma EVP Coyne sells shares worth $1.58 million By Investing.com - au.investing.com
Insider Selling: Royalty Pharma (NASDAQ:RPRX) CFO Sells 34,791 Shares of Stock - MarketBeat
Royalty Pharma EVP Coyne sells shares worth $1.58 million - Investing.com
Royalty Pharma (RPRX) CFO’s entities sell 34,791 shares under 10b5-1 plan - Stock Titan
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Nordea Investment Management AB Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
How Royalty Pharma’s New AI and Dealmaking Hires Could Shape RPRX’s Royalty Sourcing Strategy - Sahm
Royalty Pharma names Lucas Glass as head of artificial intelligence By Investing.com - Investing.com India
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance UK
Affiliates of RPRX sell multiple blocks of common stock (RPRX) - Stock Titan
Royalty Pharma plc Appoints Lucas Glass as Head of Artificial Intelligence, Effective April 2026 - marketscreener.com
Royalty Pharma names Lucas Glass as head of artificial intelligence - investing.com
Royalty Pharma plc (RPRX) Latest Stock News & Headlines - Yahoo Finance
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence - The Globe and Mail
Royalty Pharma taps IQVIA tech executive to build AI across firm - Stock Titan
How The Royalty Pharma (RPRX) Story Is Shifting With New Deals And Updated Expectations - Yahoo Finance
UBS and Citi are bullish on Royalty Pharma plc (RPRX) – here’s why - MSN
(RPRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
FOMO Trade: Will Royalty Pharma plc benefit from rate cuts2026 Setups & AI Optimized Trade Strategies - baoquankhu1.vn
Royalty Pharma PLC $RPRX Shares Purchased by Tudor Investment Corp ET AL - MarketBeat
S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Royalty Pharma Lag - Moomoo
S&P 500 Futures Decline in Premarket Trading; Super Micro Computer, Royalty Pharma Lag - Barron's
Aug Action: Does Royalty Pharma plc have high return on assets2026 Institutional & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Does Royalty Pharma plc have high return on assets2026 Institutional & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Royalty Pharma PLC $RPRX Stock Position Raised by JPMorgan Chase & Co. - MarketBeat
Royalty Pharma acquires royalty interest in Alnylam’s AMVUTTRA for $310M - MSN
RPRX: Entities report multi‑date sell notices including 136,980‑share trade - Stock Titan
Royalty Pharma plc (RPRX) earns $51 target as 2026 growth outlook exceeds expectations - MSN
[144] Royalty Pharma plc SEC Filing - Stock Titan
Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma - MSN
54,266 Shares in Royalty Pharma PLC $RPRX Acquired by WBI Investments LLC - MarketBeat
ROYALTY PHARMA PLC-CL A (NASDAQ:RPRX) Shows High Technical and Setup Ratings Ahead of Potential Breakout - ChartMill
Royalty Pharma names Greg Butz as EVP of partnering, investments By Investing.com - Investing.com South Africa
Royalty Pharma plc (RPRXN.MX) Stock Price, News, Quote & History - Yahoo Finance
Royalty Pharma Announces Expansion of Leadership Team - The Manila Times
Royalty Pharma hires Bank of America healthcare banking executive - StreetInsider
Royalty Pharma PLC $RPRX Shares Bought by L2 Asset Management LLC - MarketBeat
Royalty Pharma Plc Experiences Valuation Adjustment Amid Strong Market Performance Metrics - Markets Mojo
Dorsey Asset Management LLC Buys Shares of 2,350,449 Royalty Pharma PLC $RPRX - MarketBeat
1.79%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):